RGLS

Regulus Therapeutics Inc. - Common Stock

$0.91 +$0.03 +3.02%



Shares Bought9
Shares Sold9
Total18
Shares Owned0
Last Price$0.91
Total Return-$0.80
Range Today$0.89 - $0.93
52 Week Range$0.79 - $3.10
Open$0.89
Market Cap$91.50M
Volume/Average50.30K/866.63K
P/E Ratio-
Dividend/Yield-




Regulus Therapeutics, Inc. engages in the discovery and development of drugs targeting microRNAs. It is developing RG-101, which targets miR-122, a host factor for the hepatitis C virus infection. The company was founded in September 2007 and is headquartered in San Diego, CA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
11-07-17 20:21 11-08-17 16:12 $1.08 $0.95 -$0.13 -12.04% genovahero
11-07-17 20:21 11-08-17 16:12 $1.08 $0.95 -$0.13 -12.04% genovahero
11-07-17 20:21 11-08-17 16:12 $1.08 $0.95 -$0.13 -12.04% genovahero
11-07-17 20:21 11-08-17 16:12 $1.08 $0.95 -$0.13 -12.04% genovahero
11-07-17 20:21 11-08-17 16:12 $1.08 $0.95 -$0.13 -12.04% genovahero
11-07-17 20:22 11-09-17 14:43 $1.08 $0.95 -$0.13 -12.04% jukhunter
11-16-17 17:10 11-16-17 17:50 $0.97 $0.94 -$0.03 -3.12% kurt_woloch
08-31-17 13:30 09-06-17 20:29 $1.00 $1.01 +$0.01 +1.00% jukhunter
08-31-17 13:30 08-31-17 15:38 $1.00 $1.00 +$0.00 +0.00% jukhunter